Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimized Ablation of the Posterior Wall in Persistent Atrial Fibrillation

NCT07122336 is registered in ClinicalTrials.gov with Shanghai Chest Hospital as lead sponsor.

NCT NCT07122336
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07122336 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimized Ablation of the Posterior Wall in Persistent Atrial Fibrillation
Lead sponsor
Shanghai Chest Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
July 16, 2025
Completion date
December 31, 2026
Enrollment
384 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

persistent atrial fibrillation